Brand innovator versus multisource cefpodoxime in respiratory tract infections: A comparative study
نویسندگان
چکیده
منابع مشابه
Comparative evaluation of cefpodoxime versus cefixime in children with lower respiratory tract infections.
OBJECTIVE The emergence of penicillin and macrolide resistant strains, responsible for Acute Lower Respiratory Tract Infections in children has offered third generation cephalosporins the platform to perform. The aim of the present study was to evaluate two third generation oral cephalosporins for their empirical use in community acquired lower respiratory tract infections in pediatric patients...
متن کاملCommercial Telmisartan Tablets: A Comparative Evaluation with Innovator Brand Micardis
Purpose: Telmisartan is an angiotensin II receptor antagonist used in the management of hypertension. The solubility of Telmisartan in aqueous solutions is strongly pH-dependent. Five commercial tablets of telmisartan (40 and 80 mg) were compared with the reference formulation Micardis (Innovator brand of telmisartan molecule). Experimental: Dissolution tests were performed by employing USP typ...
متن کاملFungal Infections of Respiratory Tract-Final Section
Histoplasma capsulatum var. capsulatum, Blastomyces dermatitidis, Coccidioides immitis, Paracoccidioides brasiliensis, and Penicillium marneffei are endemic dimorphic fungi that may infect the respiratory tract. Sporothrix schenkeii, which manifests the typical thermal dimorphism of the endemic dimorphic organisms, does not seem to follow a geographically defined endemic pattern of distribution...
متن کاملClinical efficacy of cefpodoxime in respiratory tract infection.
Acute otitis media (AOM), sinusitis and tonsillopharyngitis are respiratory tract infections frequently encountered by primary-care physicians. Increasing bacterial resistance, particularly in Streptococcus pneumoniae, which is one of the most important respiratory tract bacteria implicated in community-acquired respiratory tract infections, has led to concern about the current options for empi...
متن کاملAn open comparative study of azithromycin versus cefaclor in the treatment of patients with upper respiratory tract infections.
Azithromycin and cefaclor were compared for the treatment of acute otitis media, streptococcal pharyngitis/tonsillitis, or sinusitis in an open multicentre study conducted in 530 adults. At the end of therapy (day 11-15), 228/245 (93%) patients treated with azithromycin 500 mg once daily for 3 days and 233/241 (97%) treated with cefaclor 250 mg given three times daily for 10 days were considere...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: South African Family Practice
سال: 2019
ISSN: 2078-6204,2078-6190
DOI: 10.4102/safp.v61i2.5000